Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Immunomodulatory effects associated with a live vaccine against Leishmania major containing CpG oligodeoxynucleotides

17 Nov 2006

Abstract excerpt

The inoculation of live Leishmania major to produce a lesion that heals (leishmanization) is to date the only vaccine against cutaneous leishmaniasis that has proven effective in humans, but it still has an unacceptable frequency of large ulcerating lesions that are slow to heal or, in rare cases, non-healing. We have previously shown that C57BL/6 mice vaccinated intradermally with 10(4) L. major/50 microg CpG...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Research on Leishmaniasis Studies
Share to Transgenic Plants and Applications
Share to Viral gastroenteritis research and epidemiology

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Source

Identifiers

PMID: 17109471
DOI: 10.1002/eji.200636472

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-08.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Immunomodulatory effects associated with a live vaccine against Leishmania major containing CpG oligodeoxynucleotidesPMID 17109471Read ↗

Vaccination with Heat-killed Leishmania Antigen or Recombinant Leishmanial Protein and CpG Oligodeoxynucleotides Induces Long-Term Memory CD4<b>+</b>and CD8<b>+</b>T Cell Responses and Protection Against <i>Leishmania major</i> InfectionSemantic proximity Read ↗

Cutting Edge: CpG Oligodeoxynucleotides Trigger Protective and Curative Th1 Responses in Lethal Murine LeishmaniasisSemantic proximity Read ↗

Intradermal Synthetic DNA Vaccination Generates Leishmania -Specific T Cells in the Skin and Protection against Leishmania majorSemantic proximity Read ↗

Prevention and Treatment of Cutaneous Leishmaniasis in Primates by Using Synthetic Type D/A Oligodeoxynucleotides Expressing CpG MotifsSemantic proximity Read ↗

A Review of the Role of CpG Oligodeoxynucleotides as Toll-Like Receptor 9 Agonists in Prophylactic and Therapeutic Vaccine Development in Infectious DiseasesSemantic proximity Read ↗

Adjuvantation of whole-killed Leishmania vaccine with anti-CD200 and anti-CD300a antibodies potentiates its efficacy and provides strong protection against virulent parasitesSemantic proximity Read ↗

Vaccine candidates, immuno-dominant antigens, and potent vaccine adjuvants for preventing cutaneous leishmaniasis: a sysSemantic proximity Read ↗

Live attenuated Leishmania vaccines: a potential strategic alternativeSemantic proximity Read ↗

DNA- Salmonella enterica Serovar Typhimurium Primer-Booster Vaccination Biases towards T Helper 1 Responses and Enhances Protection against Leishmania major Infection in MiceSemantic proximity Read ↗

Next-Generation Leishmanization: Revisiting Molecular Targets for Selecting Genetically Engineered Live-Attenuated LeishmaniaSemantic proximity Read ↗

Control of New World cutaneous leishmaniasis is IL-12 independent but STAT4 dependentSemantic proximity Read ↗

Leishmaniasis: Current Status of Vaccine DevelopmentSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.